Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Devin Whittemore Smith Insider Profile
4 Followers
Devin Whittemore Smith, SVP & GC at Minerva Neurosciences, holds ― shares in Minerva Neurosciences (Ticker: NERV), holds 16.94K shares in IO Biotech (Ticker: IOBT), holds 13.96K shares in Kineta (Ticker: KANT). Most recently, Devin Whittemore Smith ― shares of Minerva Neurosciences on ― for an estimated value of ―.
Devin Whittemore Smith Minerva Neurosciences (NERV)SVP & GC
Minerva Neurosciences (NERV)
SVP & GC
Ranked #51,621 out of 100,270 Corporate Insiders
Profitable Transactions
2 out of 3 Profitable Transactions
Average Return
-1.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Devin Whittemore Smith holds in companies
Most Profitable Insider Trade
The most profitable trade made by Devin Whittemore Smith
Devin Whittemore Smith's Trading History
Minerva Neurosciences
―
SVP & GC
―
―
Kineta
Dec 06, 2022
SVP & GC
Informative Sell
5.27K
$5.86K
IO Biotech
Dec 23, 2024
GC
Informative Buy
9.72K
$14.55K
List of latest transactions for each holding click on a transaction to see Devin Whittemore Smith's performance on stock
You May Also Like
Devin Whittemore Smith insider profile FAQ
What is the percentage of profitable transactions made by Devin Whittemore Smith?
The percentage of profitable transactions made by Devin Whittemore Smith is 67%.
What is the average return per transaction made by Devin Whittemore Smith?
The average return per transaction made by Devin Whittemore Smith is -1.40%.
What stocks does Devin Whittemore Smith hold?
Devin Whittemore Smith holds: NERV, KANT, IOBT stocks.
What was Devin Whittemore Smith’s latest transaction?
Devin Whittemore Smith latest transaction was an Uninformative Buy of ―.
What was Devin Whittemore Smith's most profitable transaction?
Devin Whittemore Smith’s most profitable transaction was an Informative Sell of KANT stock on June 6, 2022. The return on the trade was 10.30%.
What is Devin Whittemore Smith's role in Minerva Neurosciences?
Devin Whittemore Smith's role in Minerva Neurosciences is SVP & GC.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.